Intrexon Corp (XON) Posts Quarterly Earnings, Beats Estimates By $0.02 EPS
Intrexon Corp (NYSE:XON) posted its quarterly earnings results on Thursday. The company reported ($0.11) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.13) by $0.02, AnalystRatings.NET reports. The company had revenue of $11.80 million for the quarter, compared to the consensus estimate of $9.39 million.
Shares of Intrexon Corp (NYSE:XON) traded up 0.54% on Thursday, hitting $22.40. The stock had a trading volume of 309,147 shares. Intrexon Corp has a 52-week low of $13.13 and a 52-week high of $38.50. The stock’s 50-day moving average is $23.52 and its 200-day moving average is $24.06. The company’s market cap is $2.214 billion.
Intrexon Corporation is engaged in the business of synthetic biology. Using the Company’s suite of complementary technologies, it design, build and regulate gene programs, or sequences of deoxyribonucleic acid (NYSE:XON) that control cellular function, and cellular systems, or activities that take place within a cell and the interaction of those systems in the greater cellular environment, to enable the development of new and improved products and manufacturing processes across a variety of end markets, including healthcare, food, energy and environmental sciences.
Receive News & Ratings for Intrexon Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.